Legal Opinion
Lerner v. Northwest Biotherapeutics
District Court, D. Maryland
Decided March 31, 2017No. Case No.: GJH-15-2532PublishedCited by 11 opinions
1Opinion of the Court
MEMORANDUM OPINION
GEORGE J. HAZEL, United States District Judge
This is a securities fraud case arising from Defendants’ statements regarding the clinical trials of their cancer treatment products, “DCVax®.” Lead Plaintiffs Neil Pastel and Franklin Greer (“Plaintiffs”) bring this putative class action against Defendants Northwest Biotherapeutics, Inc. (“NW Bio” or “the Company”) and CEO Linda F. Powers (“Powers”) (collectively, “Defendants”), for purported violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (“the Exchange Act”), 15 U.S.C. §§ 78j(b), 78t, and SEC Rule…
2Cases cited44 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Albright v. OliverSupreme Court of the United States · 1994
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- H. J. Inc. v. Northwestern Bell Telephone Co.Supreme Court of the United States · 1989
- ATSI Communications, Inc. v. Shaar Fund, Ltd.Court of Appeals for the Second Circuit · 2007
39 more not listed; retrieve them via the Exa API.
3Cited by11 opinions
- Employees' Retirement System of the City of Baton v. Macrogenics, Inc.Court of Appeals for the Fourth Circuit · 2023
- Hirtenstein v. Cempra, Inc.District Court, M.D. North Carolina · 2018
- Fagen v. Enviva Inc.District Court, D. Maryland · 2024
- Fitch v. State of MarylandDistrict Court, D. Maryland · 2023
- In re Under Armour Securities LitigationDistrict Court, D. Maryland · 2019
6 more not listed; retrieve them via the Exa API.